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Current proteomic studies clarified canonical synaptic proteins that
are common to many types of synapses. However, proteins of
diversified functions in a subset of synapses are largely hidden
because of their low abundance or structural similarities to abun-
dant proteins. To overcome this limitation, we have developed an
“ultra-definition” (UD) subcellular proteomic workflow. Using pu-
rified synaptic vesicle (SV) fraction from rat brain, we identified
1,466 proteins, three times more than reported previously. This
refined proteome includes all canonical SV proteins, as well as nu-
merous proteins of low abundance, many of which were hitherto
undetected. Comparison of UD quantifications between SV and syn-
aptosomal fractions has enabled us to distinguish SV-resident pro-
teins from potential SV-visitor proteins. We found 134 SV residents,
of which 86 are present in an average copy number per SV of
less than one, including vesicular transporters of nonubiquitous
neurotransmitters in the brain. We provide a fully annotated re-
source of all categorized SV-resident and potential SV-visitor pro-
teins, which can be utilized to drive novel functional studies, as we
characterized here Aak1 as a regulator of synaptic transmission.
Moreover, proteins in the SV fraction are associated with more than
200 distinct brain diseases. Remarkably, a majority of these proteins
was found in the low-abundance proteome range, highlighting its
pathological significance. Our deep SV proteome will provide a fun-
damental resource for a variety of future investigations on the func-
tion of synapses in health and disease.
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The functions of eukaryotic cells, in all their complexity, dependupon highly specific compartmentalization into subcellular
domains, including organelles. These compartments represent
functional units characterized by specific supramolecular protein
complexes. A major goal of modern biology is to establish an ex-
haustive, quantitative inventory of the protein components of each
intracellular compartment. Such inventories are points of depar-
ture, not only for functional understanding and reconstruction of
biological systems, but also for a multitude of investigations, such
as evolutionary diversification and derivation of general principles
of biological regulation and homeostasis.
Essential to communication within the nervous system, chem-
ical synapses constitute highly specific compartments that are
connected by axons to frequently distant neuronal cell bodies.
Common to all chemical synapses are protein machineries that
orchestrate exocytosis of synaptic vesicles (SVs) filled with neu-
rotransmitters in response to presynaptic action potentials (APs),
resulting in activation of postsynaptic receptors. Moreover, syn-
apses are composed of structurally and functionally distinct sub-
compartments, such as free and docked SVs, endosomes, active
zones (AZs) at the presynaptic side, and receptor-containing
membranes with associated scaffold proteins on the postsynaptic
side. Thus, it is not surprising that mass spectrometry (MS)-based
proteomics, combined with subcellular fractionation, yields pro-
tein inventories of high complexity. For instance, >2,000 protein
species were identified in synaptosomes (1), ∼400 in the SV fraction
(2), ∼1,500 in postsynaptic densities (3), and ∼100 in an AZ-
enriched preparation (4).
While these studies provide insights into the protein compo-
sition of synaptic structures, they are still inherently limited for
two reasons. First, synapses are functionally diverse with respect
to the chemical nature of their neurotransmitters, as well as their
synaptic strength, kinetics, and plasticity properties (5). There-
fore, analyzed subcellular fractions represent “averages” of a
great diversity of synapses (6) or SVs (2). The second limitation
is that proteins known to be present in specific subsets were not
found in these studies, despite the unprecedented sensitivity of
modern mass spectrometers. In fact, many functionally critical
synaptic proteins have remained undetected. For example, the
synaptotagmin (Syt) family, major Ca2+ sensors of SV exocytosis,
comprises >15 members, of which only 5 had been identified in
previous SV proteomics (2, 4, 7). Missing isoforms included Syt7,
involved in asynchronous transmitter release (8), synaptic plas-
ticity (9), and SV recycling (10). Likewise, the vesicular trans-
porters for monoamines (VMATs) and acetylcholine (VAChT)
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neurotransmitters were missing in these studies. Clearly, known
components of the diversified synaptic proteome have been missing,
and it is not possible to predict how many more such proteins
remain hidden.
What are the reasons for the continuing incompleteness of the
synaptic protein inventory? Proteome identification and quanti-
fication rely heavily on MS detectability of peptides generated by
digestion of extracted proteins with sequence-specific enzymes,
such as trypsin. However, in MS analysis of complex biological
samples, peptide signals from a few abundant proteins often mask
those that are less abundant. Additionally, the probability of
obtaining peptides with similar masses, but different amino acid
sequences, increases with increasing sample complexity (11, 12). To
overcome these limitations, we have elaborated a workflow with
dual-enzymatic protein digestion in sequence combined with an
extensive peptide separation prior to MS analysis. As proof of
concept, we have utilized purified SV fractions from rat whole
brain, which serve as a benchmark for quantitative organellar
proteomics (2). As a result, we detected ∼1,500 proteins in the SV
fraction, three times more than reported previously. This proteome
not only covers all known canonical SV proteins but also contains
proteins previously overlooked, such as the low-abundance Syts
and SV transporters. Moreover, peptide quantification allowed for
differentiating “SV-resident” from “SV-visitor” proteins. In fact,
most “SV-resident” proteins revealed in our SV proteomics are of
low abundance, with an average copy number of less than 1 per SV,
suggesting a larger molecular and functional diversity of SVs than
previously thought. Remarkably, more than 200 proteins detected
in the SV fraction are genetically associated with brain disorders,
76% of which were previously hidden.
Results
A Workflow with Enhanced Peptide Recovery and Separation Greatly
Extended Synaptic Proteome Coverage. A workflow was developed
to increase coverage of protein-specific sequences or “unique
peptides” prior to MS identification. First, to increase the
number of accessible cleavage sites, we introduced Lys-C treat-
ments before and during tryptic digestion (Fig. 1A and SI Ap-
pendix, Fig. S1). Second, to improve separation of the peptides,
we introduced off-line fractionation using electrostatic repulsion-
hydrophilic interaction chromatography (ERLIC), based on their
charges, polarities, isoelectric pH, posttranslational modifica-
tions, and orientations (13, 14), prior to conventional
hydrophobicity-based reverse-phase chromatography (RPC). To
evaluate the contribution of this workflow to greater protein cover-
age, we also ran a conventional protein digestion-peptide separation
protocol combined with modern mass spectrometer (Q-Exactive
Plus) analyses, which we designated as the “high-definition” (HD)
method, whereas we refer to our workflow as the “ultra-definition”
(UD) method (Fig. 1B and SI Appendix, Fig. S1). The UD-based
proteomics revealed 1,466 proteins in the SV fraction (Fig. 1C). This
is twice as many as with the HD method (766), and more than three
times as many as previously reported (2). The increased sensitivity of
the UD method is also evident from the recovery of unique peptides
of individual proteins. For instance, 116 unique peptides were
identified for the large AZ protein Piccolo whereas the HD method
recovered only 14, and only 1 was identified in the previous study (2)
(Fig. 1B). The UD method increased not only the size of the SV
proteome, but also the number of isoforms identified within indi-
vidual protein families, such as the Syts (Fig. 1D), for which most
known family members were detected (13 of 15 and extended-Syt1).
The previously undetected isoforms include Syt7, which was recently
found to regulate multiple modes of neurotransmitter release
(8–10). In contrast, the HD method added only one Syt isoform to
the previous SV proteome (2).
As expected, the UD method also detected a much greater
number of proteins (4,439) in synaptosomal fractions (P2′) than
the HD method (1,790) (SI Appendix, Fig. S1A), indicating that
the resolving power of the UD method is based upon improved
workflow prior to MS analysis (SI Appendix, Fig. S1). Note that
each sample used for our MS analyses was checked by electron
microscopy (EM) and electrophoresis. Typical synaptosomal
profiles were observed in P2′ samples whereas uniform vesicle
structures of 40 to 50 nm in diameter predominated SV fractions
(Fig. 1E). Proteins extracted from the P2′ and SV fractions
showed distinct sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS/PAGE) profiles (Fig. 1F).
Improved Quantification Revealed the Synaptic Organization and
Diversity of the SV Proteome. In quantitative MS, protein abun-
dance can be determined using intensity-based absolute quanti-
fication (iBAQ), a label-free approach in which the summed
intensities of all unique peptides of a protein are divided by the
total number of unique peptides detected. Thus, the increased
peptide recovery achieved with the UD method is expected to
improve the accuracy of protein quantification. To test this as-
sumption, we performed immunoblot analyses for 41 proteins in
the fractions during SV purification and compared with the
quantification profiles of the HD and UD methods (SI Appendix,
Fig. S2). As expected, proteins located at the postsynaptic side or
in the synaptic cleft were found in the P2′ fraction, but not in the
SV fraction, both in immunoblot and MS analyses (SI Appendix,
Fig. S2A). Proteins residing on SVs were found at higher levels in
the SV than the P2′ fraction, in both Western blot and UD
analyses (SI Appendix, Fig. S2B). In contrast, the HD method
failed to detect some SV proteins in P2′. Similar inconsistencies
between HD iBAQ data and immunoblot profiles were found for
proteins in AZ, presynaptic membrane, and cytoplasm (SI Ap-
pendix, Fig. S2 C–E): altogether in 30% (13 of 41) of cases.
These results highlight the importance of the UD workflow for
quantitative proteomics.
SVs are purified from synaptosomes (P2′), which contain all SV
proteins, whereas SVs may not contain proteins from other syn-
aptic compartments. Of 4,424 proteins in the P2′ fraction, 3,005
were detected only in P2′, including postsynaptic and mitochon-
drial proteins (Fig. 2A). Of 1,466 SV proteins, 1,419 were detected
in P2′. The remaining 47 SV proteins were of low abundance,
including VGLUT3, a vesicular glutamate transporter isoform
present in a limited set of central nervous system (CNS) synapses.
To evaluate possible contamination of postsynaptic proteins into
the SV fraction, we have referred to the Synaptic Gene Ontologies
(SynGO) resource (15). Of all SV fraction proteins, 97 (7%) are
annotated as postsynaptic proteins, but 47 out of 97 proteins are
reportedly present and function in presynaptic compartments
(Dataset S1). Thus, contamination of postsynaptic proteins in the
SV proteome seems minor within the proteins detected in the
SynGO database.
To distinguish SV residents from proteins transiently inter-
acting (“visitors”) with SVs, we determined the iBAQ ratio SV/
P2′ in a volcano plot (Fig. 2B). Of 1,466 SV proteins, 134 had an
SV/P2′ ratio significantly higher than 2 (P < 0.05). We used this
criterion to define the bona fide “SV-resident” protein group. It
comprised all previously established SV proteins (2, 16, 17), as
well as hitherto uncharacterized proteins (see The “Hidden SV
Proteome” Uncovered by the UD Proteomic Method). On the other
hand, a majority of the 1,466 proteins had an SV/P2′ ratio lower
than 1, suggesting that these occasionally interact with SVs. We
defined them as potential SV-visitor proteins. This repertoire
contains 1) cytosolic proteins, such as calmodulin, actin, and
synaptojanin-1; 2) AZ proteins, such as Piccolo and Bassoon;
and 3) plasma membrane proteins, such as syntaxin-1, all of
which interact transiently with SVs, for instance, in the SV
trafficking pathway (4, 18, 19). Thus, UD proteomics provide
quantitative information to distinguish SV-resident and SV-
visitor synaptic protein repertoires.








We next ranked the 1,466 proteins detected in the SV fraction
by iBAQ abundance (Fig. 2C and Dataset S1). We confirmed
that previously reported canonical transmembrane proteins and
lipid-anchored proteins were highly abundant (see the word
cloud chart in Fig. 2C). The 180 most abundant protein species
accounted for 90% of the total protein mass of SVs, having
iBAQs of >1.2 × 108 (1.2E8) (Fig. 2C). The iBAQ of the
remaining 1,286 proteins ranged from E5 to E8. Previously, copy
numbers per SV were estimated for abundant SV proteins to
construct an “average SV” model (2, 6). Using isotope-labeled
peptides, we extended the copy number estimate to all other
detected SV proteins (SI Appendix, Fig. S3 and Table S1). As a
calibration standard, we utilized the previously determined copy
number of Syt1: 15 (2). The copy number estimated by this
method for Rab3A was 10.5, which nearly coincided with the
copy number of 10 previously determined by immunoblotting
(2), confirming the accuracy of this method. These analyses in-
dicated that copy numbers of many SV proteins are below 1,
suggesting that they are present only in subpopulations of SVs or
only transiently interact with SVs.
The “Hidden SV Proteome” Uncovered by the UD Proteomic Method.
To reveal the hidden SV proteome, we tabulated an SV protein
inventory detected by UD proteomics with annotations (Dataset
S1), including comparisons with those by Takamori et al. (2).
This inventory allows one to extract novel insights into SV
structure and function using various filters, such as gene family
names, abundance rank, and molecular, structural, or functional
categories. The first example selected from the inventory is the
Rab GTPases, which function in vesicle transport to specific
subcellular organelles and membranes (20). They are evolu-
tionally conserved, displaying 75 to 95% amino acid sequence
identity. Such high homology has hampered proteomic detec-
tion, but, using UD proteomics, we detected and quantified 40
Rabs in the SV fraction, of which 8 were hitherto unreported. Of
32 Rabs previously documented (2), abundance was quantified
for only 18 using Western blot analysis (21). We found a majority
of high-abundance Rabs (25 of 40) significantly enriched in the SV
fraction (SI Appendix, Fig. S4B). Among them, Rab11A and
Rab11B are highly homologous, with 91% amino acid sequence
identity (Fig. 3A). Despite such similarity, they reportedly function
in opposing endosomal sorting routes (22). We found 14 unique
peptides common to both Rab11A and -B; however, only UD
proteomics could detect a Rab11A signature in the C-terminal
hypervariable region. Thus, UD proteomics can reveal highly ho-
mologous, but functionally distinct, proteins.
The second example is the vacuolar-type H+-ATPase (V-ATPase)
protein complex, which operates as an ATP-driven proton pump to
energize SVs for neurotransmitter uptake. The V-ATPase complex
is composed of a cytoplasmic domain “V1” comprising eight sub-
units (A to H), and a transmembrane domain “V0” assembled from
four subunits (a, c, d, and e) (23) (Fig. 3B). Previous proteomic
studies estimated the copy number of V-ATPase as ∼1 to 2 per SV,
but the complete set of V-ATPase proteins remains unidentified (2,
4, 17). Intriguingly, using UD proteomics, we identified all compo-
nents of the V-ATPase complex, most of which were found in the
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Fig. 1. UD proteomics tripled the known SV proteome size. (A) Key steps in the UD proteomics method: sequential enzymatic digestion steps followed by
orthogonal peptide separations using multiple biophysical properties of amino acids (SI Appendix, Fig. S1) (IAA, iodoacetamide). (B) Unique peptide coverage
by MS of the AZ protein Piccolo (highlighted amino acid sequence) in Takamori et al. (2), HD and UD proteomic methods. (C) Numbers of proteins identified in
the SV fraction by Takamori et al. (2) (yellow), HD (white), and UD (gray) methods. (D) Syt family members identified in the SV fraction by Takamori et al. (2),
HD and UD methods. (E) EM images of the purified synaptosome (P2′) and SV fractions, showing clear vesicles with diameters of ∼40 nm. (Bottom) Rep-
resentative synaptic structures in the P2′ fraction in EM images, showing intact subsynaptic compartments, as illustrated (PSD, postsynaptic density). (F) SDS/
PAGE profiles of proteins extracted from the P2′ and SV fractions.
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high-abundance range of the SV proteome (Fig. 3B and Dataset S1).
Furthermore, V-ATPase accessory proteins Wdr7 and renin recep-
tor (atp6ap2), and previously hidden Dmxl1 and Dmxl2, were all
identified (24) (Fig. 3B). These low-abundance accessory proteins, in
which only renin receptors are categorized as SV-resident (Dataset
S1), may regulate V-ATPase complex functions in a restricted subset
of SVs. Thus, the UD method can reveal full sets of subunits com-
prising large protein complexes.
The third example is SV-resident transporter proteins. Solute
carrier (“slc”) transporters are transmembrane proteins that
control movements of soluble molecules across cellular mem-
branes. To date, more than 400 slc genes have been identified in
mammals, of which ∼40% remain uncharacterized with respect to
their expression profiles and functions (25). Our UD analysis
detected slc transporters both in SV-resident and SV-visitor rep-
ertoires (Fig. 3C). The latter may include transporters partially
internalized from the plasma membrane into SVs during endo-
cytosis (SI Appendix, Fig. S5). SV-resident transporters include
VGLUT1 (slc17a7) and VGLUT2 (slc17a6) responsible for glu-
tamate uptake, and VGAT (slc32a1) for GABA and glycine up-
take, all of which define the molecular identities of the major SV
populations in the brain (26), and which occur at high abundance
in the SV proteome (Fig. 3C). UD proteomics also detected lower
abundance SV-resident transporters that were missing in previous
SV proteomic studies. These include VMAT2 (slc18a2) (27),
ChT1 (slc5a7) (28), VAChT (29), involved in uptake of mono-
amines or ACh into SV subpopulations, and SVOP of unknown
substrate (atypical slc subfamily) (30). In addition to these well-
known transporters, UD analyses revealed nine SV-resident
transporters (Fig. 3C), among which slc10a4 reportedly trans-
ports bile acids into SVs to modulate dopamine activity (31). The
remaining eight transporters are orphan slcs of unknown function
(SI Appendix, Table S2). Thus, UD proteomics have unveiled and
quantified hidden transporter proteins of both high and low
abundance in the SV proteome, having ubiquitous or restricted
presence in SV populations.
The fourth example is a discovered protein in the SV fraction
(Fig. 4). In data banks, this protein is known as RGD1305455
(Uniprot IDA0A0G2KAX2) or as “uncharacterized protein C7orf43
homolog” and “similar-to-hypothetical protein FLJ10925.”Nothing is
known regarding its tissue expression, developmental profile, or
subcellular localization. Six unique peptides from RGD1305455 were
detected only in UD experiments (Fig. 4A). RGD1305455 was found
as an SV-resident protein (SV/P2′ ratio = 3) of low abundance (rank
407; copy number/SV ∼0.04) (Fig. 4 A and B). It harbors a conserved
DUF domain (DUF4707) and lacks a predicted transmembrane
domain. Database searches revealed that the protein is highly
conserved among mammals (>97% amino acid identity) (Fig. 4C
and SI Appendix, Table S3). To confirm its presence in the SV
fraction, we employed a targeted proteomic strategy. The UD
unique peptide VLVVEPVK (Fig. 4A) was chemically synthesized
using a “heavy” C-terminal lysine (13C6 and
15N2) and mixed with a
digested SV protein sample. A parallel reaction monitoring (PRM)
assay based on elution time, ionization, and fragmentation of the
A B
C
Fig. 2. Synaptosomal organization and diversity of the SV proteome revealed by UD proteomics . (A) Numbers of synaptosomal proteins detected in either or
both P2′ and SV fractions. (B) Volcano plot showing synaptosomal protein distribution in SV over P2′ fractions; x axis (log2 scale), mean iBAQ (SV/P2′) ratio; y
axis (log10 scale), probability of statistical significance (P value, from three independent experiments). The horizontal red dashed line indicates P = 0.05;
vertical dashed lines indicate ratios of 1/2 and 2, respectively. (C) Relative abundance of SV proteins in a “word cloud” representation (Inset) and in a ranked
(iBAQ) abundance curve of the SV proteome. Shown are estimated copy numbers per SV (SI Appendix, Fig. S3) are indicated with horizontal dashed lines. The
vertical dashed line indicates proteins accounting for 90% of the total mass of SV. Names of representative proteins are indicated. Previously undetected SV
proteins are marked in red. Abbreviations in parentheses denote the following: TM, transmembrane; LA, lipid-anchored; and S, soluble proteins.
































detected Rab11 peptides specificity method
NILTEIYR Rab11B HD/UD
NNLSFIETSALDSTNVEEAFKNILTEIYR Rab11B HD/UD
NGLSFIETSALDSTNVEAAFQTILTEIYR Rab11A UD only
AITSAYYR Rab11A and B HD/UD
SIQVDGK Rab11A and B UD only
VVLIGDSGVGK Rab11A and B HD/UD
SIQVDGK Rab11A and B UD only
GAVGALLVYDIAK Rab11A and B UD only
FTRNEFNLESK Rab11A and B HD/UD
STIGVEFATR Rab11A and B HD/UD
HLTYENVER Rab11A and B HD/UD
SNLLSR Rab11A and B UD only
AQIWDTAGQER Rab11A and B HD/UD
DHADSNIVIMLVGNK Rab11A and B HD/UD
NEFNLESK Rab11A and B UD only
GTRDDEYDYLFK Rab11A and B HD/UD
AVPTDEAR Rab11A and B UD only
106. Wdr7 (S)
121. Renin receptor (TM)
122. Ac45 (TM)










































5. V-ATPase V0-a1 (TM) 
10. V-ATPase V0-d1 (TM) 
15. V-ATPase V1-A  (S)
18. V-ATPase V1-E1 (S) 
26. V-ATPase V1-B2 (S)
60. V-ATPase V1-B1 (S)
69. V-ATPase V1-G1 (S)
70. V-ATPase V1-C1 (S)
86. V-ATPase V1-G2 (S)
87. V-ATPase V1-H (S)
88. V-ATPase V0-c (TM)
101. V-ATPase V1-D (S)
105. V-ATPase V1-F (S)




























































































































Fig. 3. UD proteomics unveiled hidden proteins in both high- and low-abundance ranges of the SV proteome. (A) UD proteomics distinguish highly ho-
mologous protein isoforms, Rab11A and Rab11B. (Left) Positions of Rab11A and Rab11B in the ranked (iBAQ) abundance curve. (Middle) Amino acid sequence
alignment of Rab11A and Rab11B, showing 91% identity. (Right) List of unique Rab11 peptides detected in the SV fraction by HD and UD methods. Rab11A is
identified only by UD from a unique peptide at the C-terminal region of Rab GTPase. (B, Left) V-ATPase–related proteins detected in the SV fraction on the
ranked (iBAQ) abundance curve. Right illustration: Structural model of the V-ATPase protein V0 (a, c, and d) and V1 (A to H) subunits in SVs. Proteins revealed
by UD proteomics are indicated in red. (C) SV-resident transporter proteins revealed in the SV fraction by UD proteomics (red), known but missing in previous
proteomic studies (purple) in the SV-P2′ volcano plot (Left) and Venn diagram (Right Top). (Right Bottom) Position of the transporters in the ranked (iBAQ)
abundance curve of the SV proteome.
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heavy peptide detected a matched VLVVEPVK peptide in the SV
sample (Fig. 4D). Close comparison between observed and expec-
ted peptide fragments (SI Appendix, Table S4) indicated that mass
errors of native fragments fell within 0.02 dalton (Fig. 4D), con-
firming with high precision that protein RGD1305455 indeed exists
in the SV fraction. Likewise, in PRM assays using 15 other heavy
peptides for hitherto unidentified SV-resident proteins (SI Appen-
dix, Table S5), the presence of all of the tested proteins in the SV
fraction was confirmed.
Functional Characterization of an SV-Associated Kinase Protein, Aak1.
The SV fraction contained numerous nontransmembrane pro-
teins, some of which reside with SVs within the synaptic com-
partment (Dataset S1). These proteins might play a regulatory
role in neurotransmission. To address this, we focused our
analyses on protein kinases, which are mostly soluble cytoplasmic
proteins. We identified AP2-associated protein kinase 1 (Aak1)
as an abundant and SV-resident kinase (Fig. 5 A and B). The
copy number of Aak1 was calculated as 1.5/SV (SI Appendix, Fig.
S3 and Table S1), suggesting a ubiquitous presence among SVs
in central synapses (Fig. 5B). The enriched profile of Aak1 in the
purified SV fraction was confirmed by Western blot, contrasting
with other cytoplasmic kinases found in P2′, such as MARK2 or
TNiK (SI Appendix, Figs. S2E and S6B). In cultured hippocam-
pal neurons, strong colocalization of exogenously expressed
Aak1 (TagRFP-Aak1) with an SV marker, synaptophysin-
pHluorin (SypHy), was observed (Fig. 5C).
We employed both genetic and pharmacological approaches
to clarify the functional role of Aak1, using short hairpin RNA
(shRNA) knockdown (KD) of Aak1 expression in cultured hip-
pocampal neurons, and by infusing an Aak1-specific inhibitor,
LP-935509 (32), directly into the calyx of Held presynaptic ter-
minals in brainstem slices of rats at postnatal day (P) 13 to 15.
For Aak1-KD, we applied a lentivirus targeting Aak1 at day 11
in vitro (DIV11), when synaptophysin became detectable in
Western blot (SI Appendix, Fig. S6A). At DIV15, the KD effect
became maximal, reducing Aak1 expression below 5% (Fig. 5D).
In hippocampal culture at DIV15, excitatory postsynaptic cur-
rents (EPSCs) in Aak1-KD neurons underwent a rapid short-
term depression (STD) during stimulation at 20 Hz. The mag-
nitude of STD was significantly greater than that in controls
(P < 0.05, n = 7) (Fig. 5E). Consistently, at the calyx of Held
loaded with LP-935509, EPSCs underwent stronger STD during
a 100-Hz train compared to controls (0.3 s, P < 0.05, n = 7) (SI
Appendix, Fig. S6C). Cumulative histograms of EPSC amplitudes
provided the pool size of readily releasable SVs and release
probability, indicating that both Aak1-KD (Fig. 5E) and Aak1
inhibitor (SI Appendix, Fig. S6C) reduced the pool size without
affecting the release probability. Furthermore, the recovery from
STD was prolonged, both at the Ca2+-dependent fast component
(33) and Ca2+-independent slow component at the calyx of Held
(Fig. 5F). These results together suggest that Aak1 normally
facilitates SV recycling, thereby maintaining the releasable SV
pool.
To further investigate whether Aak1 is involved in exo-
endocytosis of SVs, we performed pHluorin assays in cultured
hippocampal neurons (Fig. 5G) and capacitance measure-
ments at the calyceal terminal (Fig. 5H). In pHluorin assays,
endocytic fluorescence half-decay time was prolonged by twofold
(P < 0.005, n = 51) compared to controls (n = 20). Likewise, in
capacitance measurements, LP-935509 (1 or 10 μM) significantly
prolonged the endocytic capacitance change. Capacitance mea-
surements did not indicate a significant reduction of exocytosis.
Thus, both at hippocampal and brainstem synapses, Aak1 likely
plays an accelerating role in SV endocytosis.
Since the above results suggest involvements of Aak1 in the SV
recycling pathway, we further investigated whether Aak1 might
have a physiological role in the maintenance of neurotransmission.
Simultaneous recordings of presynaptic and postsynaptic APs in-
dicated that the Aak1 inhibitor (1 μM) significantly impaired the
fidelity of neurotransmission, assayed as a ratio of postsynaptic
APs generated in response to presynaptic APs (P < 0.01, n = 6)
(Fig. 5I). Altogether, our data indicate that Aak1 is a canonical
SV-resident protein with an essential functional role in mainte-
nance of neurotransmission, particularly at high frequency.
Many Low-Abundance SV Proteins Are Linked to a Diverse Range of
Physiological Functions and Neurological Disorders. Many proteins
were uncovered by UD proteomics in both high- and low-
abundance ranges of the SV fraction proteome, with >80%
found in lower ranges (Dataset S1). Even though expressed at low
abundance, SV proteins may play important physiological roles.
We investigated this possibility using functional and disease an-
notations in our database, by classifying SV proteins into 17
functional categories with 26 subcategories (Fig. 6A). Our dataset
contains trafficking proteins including SNAREs involved in vari-
ous membrane fusions (26 protein species) (2, 6). It also contains
many types of Rab GTPases (40 species) and membrane-tethering
Trapp complexes (14 proteins) (SI Appendix, Fig. S4). Many of
these proteins are identified as SV-resident, suggesting that SVs
may be equipped with proteins for various trafficking routes to-
ward other presynaptic organelles. Other major categories in-
cluded proteins involved in signaling (e.g., kinases, phosphatases),
signal transduction, and transport of small molecules. UD
proteomics detected a high number of metabolic enzymes (179
species), including those involved in neurotransmitter metab-
olism (13 species), cellular energy production (35 species), lipid
regulation (75 species), and cyclic nucleotide second messen-
gers (12 species). These data suggest the occurrence of meta-
bolic reactions on SVs in crowded presynaptic terminals (6).
UD proteomics also detected SV proteins categorized as
autophagy-related proteins (40 protein species) (SI Appendix,
Fig. S4D). The presence of both SV-resident (e.g., snap29,
atg9a, trappc8, and pik3c3) and SV-visitor autophagy-related
proteins (e.g., beclin-1, uvrag, map1lc3a, and cisd2) in our SV
proteome (SI Appendix, Fig. S4D and Dataset S1) suggests that
autophagic degradation may participate in the maintenance of SV
population size within presynaptic terminals.
To examine the pathological implications of our UD proteo-
mics data, we searched for genetic information on SV proteins
regarding their associations with neurological diseases (see
“Diseases in the SV fraction” in Dataset S1) and marked them in
ranked abundance plots of SV (Fig. 6B) and P2′ fraction pro-
teomes (SI Appendix, Fig. S7). We found that 236 different brain
diseases are associated with 210 high- and low-abundance pro-
teins of the SV proteome, of which 159 (76%) are revealed by
the UD method. Likewise, 55% of these SV proteins were found
in low-abundance ranges of the P2′ proteome (SI Appendix, Fig.
S7). These results indicate the pathological significance of SV
proteins irrespective of their abundance. SV protein-associated
diseases include many motor (145 associated proteins), cognitive
(135 proteins), and sensory system phenotypes, such as visual (33
proteins) and auditory (14 proteins) phenotypes. The database also
indicates SV proteins associated with phenocopy diseases, such as
mental retardation (28 disease phenotypes), epilepsy (25 pheno-
types), Parkinson’s disease (13 phenotypes), amyotrophic lateral
sclerosis (4 phenotypes), Alzheimer’s disease (4 phenotypes), and
cerebellar ataxia (10 phenotypes). Our UD cross-analyses between
functions and diseases indicate that phenocopies may involve pro-
teins from both SV-resident and SV-visitor repertoires, from
both high- and low-abundance ranges, and from functionally
distinct proteins in the SV life cycle. For example, Parkinson’s
disease can be linked to mutations in SV-resident proteins such
as renin-receptor (121st rank), involved in SV acidification,
dnajc13 (318th rank, SV endocytosis) and sv2c (97th rank, SV
trafficking), or in SV-visitor proteins, such as synaptojanin-1
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B. floridae 86 HHEGGLERGTVPVSNGKQDFRDCVPLLLHNSSAKDQAE--------------KGEDPVTV
P. humilis 126 -PGNFG-NDEREDSKEPPVFRECRALLTHSRGPPGSAGA------------GLPVDDPIV
A. ocellaris 140 AAEAAIAALGSRVDSRCRNFRDCKPLLIHNSSGT-------ASREFRRAPVQSPLDEPVV
P. sinensis 87 PPEGPG-TDGAAPPPNPSQFRDCCPLLTHGQGPPGRPAA-----GVRRDPGEIPVEEPIV
D. leucas 297 RPEGRGTLEGSGRPMTGEERGGREPHTADLKGNAGAAGGLDSSDLFTLFTTQLPVEEPIV
R. norvegicus 109 DPGGGGLFRS------------CSPLLTHGPG-----------PATSGGATTLPMEEPIV
M. musculus 109 DPGGGGLFRG------------CSPLLTHGQG-----------PATSGGATTLPVEEPIV
L. africana 289 DPGGGGLFRG------------CSPLLTHGPG-----------PATSGGATTLPVEEPIV
P. abelii 110 DPGGGGLFRG------------CSPLLTHGPG-----------PATSGGATTLPVEEPIV
H. sapiens 109 DPGGGGLFRG------------CSPLLTHGPG-----------PATSGGATTLPVEEPIV
C. jacchus 109 DPGGGGLFRG------------CSPLLTHGPG-----------PATSGGATTLPVEEPIV
B. floridae 179 -------------PAESV-------EEQVT--KEVKESSDVKCHV--------------Y
P. humilis 292 GTGGYLRLLQGRAPGQVFRQQHGAFKAQVSTLLTVLPPPRVRCRQVTVSGKYLTVLKVLN
A. ocellaris 234 --LGYLSVLQQREPTHTFRHDLNTFKAQVSTTLTVLPSPTVRCKQMTVSGRQLAVLKVLN
P. sinensis 182 --HGYLSLLQNRAPGQLFHEEQGAFKAQVSTMLTVLPPPGLKCRQLNVSGKYPTXXSVLN
D. leucas 398 --QGYLRLLQTRSPGETFRGEQSAFKAQVSTLLTLLPPPVLKCRQFTVAGKHLTVLKVLN
R. norvegicus 187 --QGYLRLLQTRSPGETFRGEQSAFKAQVSTLLTLLPPPVLKCRQFTVAGKHLTVLKVLN
M. musculus 187 --QGYLRLLQTRSPGETFRGEQSAFKAQVSTLLTLLPPPVLKCRQFTVAGKHLTVLKVLN
L. africana 367 --QGYLRLLQTRSPGETFRGEQSAFKAQVSTLLTLLPPPVLKCRQFTVAGKHLTVLKVLN
P. abelii 188 --QGYLRLLQTRSPGETFRGEQSAFKAQVSTLLTLLPPPVLRCRQFTVAGKHLTVLKVLN
H. sapiens 187 --QGYLRLLQTRSPGETFRGEQSAFKAQVSTLLTLLPPPVLRCRQFTVAGKHLTVLKVLN
C. jacchus 187 --QGYLRLLQTRSPGETFRGEQSAFKAQVSTLLTLLPPPVLRCRQFTVAGKHLTVLKVLN
B. floridae 203 NSSCEDVTVHQLQIIPNCNAAFQHDSAEKTSPQPNIQTPSKRTAEGGLFSLVHTDPSQLP
P. humilis 352 GSSQEELSLWDVQILPNFNASYLPVMPDGSVLLVDDVCHHSGEVPVGAFCRVPGGQAGWP
A. ocellaris 292 ESSQEEVSIRDVRILPNLNASYLPMMPDGSVLLVDNVCHQSGEVGMASFCRVDSLACRLP
P. sinensis 240 GCSQDEISLWDIRILPNFNASYLPMLPDGSVMLVDDVCHHSGEVPVGAFCRVAGAGSSCP
D. leucas 456 SSSQEEISIWDIRILPNFNASYLPVMPDGSVLLVDNVCHQSGEVSMGSFCRLPGTSGCFP
R. norvegicus 245 SSSQEEISIWDIRILPNFNASYLPVMPDGSVLLVDNVCHQSGEVSMGSFCRLPGTSGYFP
M. musculus 245 SSSQEEISIWDIRILPNFNASYLPVMPDGSVLLVDNVCHQSGEVSMGSFCRLPGTSGYFP
L. africana 425 SSSQEEISIWDIRILPNFNASYLPVMPDGSVLLVDNVCHQSGEVSMGSFCRLPGTSGCFP
P. abelii 246 SSSQEEISIWDIRILPNFNASYLPVMPDGSVLLVDNVCHQSGEVSMGSFCRLPGTSGCFP
H. sapiens 245 SSSQEEISIWDIRILPNFNASYLPVMPDGSVLLVDNVCHQSGEVSMGSFCRLPGTSGCFP
C. jacchus 245 SSSQEEISIWDIRILPNFNASYLPVMPDGSVLLVDNVCHQSGEVSMGSFCRLPGTSGCFP
B. floridae 263 SHLQPLEELCLVFQIVVNDNWNAGKYESHESALLLLMLWQPGKAVNSNSSEEHIHTHYSL
P. humilis 412 CPLSALEEQNFLFQLQAPERPPCDSKEGLEVPLVAVVRWSTPKLPF----TNSIVTHYRL
A. ocellaris 352 SMLSSLEEHDFLFQLHLNDMPQDDSNEGLEVPLVAVLQWSTPKMPF----TNCIYTHYRL
P. sinensis 300 CALSALEEQNFLFQLQAPERPQEDTKEGLEVPLVAVVQWSTPKLPF----TSSIYTHYRL
D. leucas 516 CLLSALEEHNFLFQLRGGEQPPPGAKEGLEVPLIAVVQWSTPKLPF----TQSIYTHYRL
R. norvegicus 305 CPLSALEEHNFLFQLRGGEQPPPGAKEGLEVPLIAVVQWSTPKLPF----TQSIYTHYRL
M. musculus 305 CPLSALEEHNFLFQLRGGEQPPPGAKEGLEVPLIAVVQWSTPKLPF----TQSIYTHYRL
L. africana 485 CPLSALEEHNFLFQLRGGEQPPPGAKEGLEVPLIAVVQWSTPKLPF----TQSIYTHYRL
P. abelii 306 CPLNALEEHNFLFQLRGGEQPPPGAKEGLEVPLIAVVQWSTPKLPF----TQSIYTHYRL
H. sapiens 305 CPLNALEEHNFLFQLRGGEQPPPGAKEGLEVPLIAVVQWSTPKLPF----TQSIYTHYRL
C. jacchus 305 CPLNALEEHNFLFQLRGGEQPPPGAKEGLEVPLIAVVQWSTPKLPF----TQSIYTHYRL
RGD1305455





































































Fig. 4. A previously hidden SV-resident protein shows high amino acid sequence homology among mammals. (A) “Uncharacterized Protein RGD1305455”
(Uniprot ID A0A0G2KAX2), identified in UD proteomics from unique peptides (highlighted within amino acid sequence) and its position in the ranked (iBAQ)
abundance plot (Lower). No unique peptide could be detected with the HD method. (B) SV-resident position of RGD1305455 in the SV-P2′ volcano plot. (C)
Amino acid sequence comparison of RGD1305455 homologs in various animal species. Black and gray shading indicates identical and similar amino acids,
respectively. Dashes represent gaps in sequences. See SI Appendix, Table S4 for protein accession numbers and reference sequences. Mammal species are
framed in dashed red line boxes (Left) and species pictures with >97% identity (Right). (D) Confirmation of the existence of RGD1305455 protein in the SV
fraction using a targeted proteomic approach. VLVVEPVK peptide (detected in UD proteomics) was synthesized using C-terminal “heavier” [13C6
15N2] lysine
(+ eight neutrons = a predefined shift of 8 Da) and was used to track native peptides after mixing with digested SV proteins. (Left) MS2 spectra of heavy
VLVVEPVK peptide. (Right) MS2 spectra of a native peptide detected in the SV fraction that coincides with that of the heavy peptide. Red, blue, and black
peaks indicate matched y-ion series, b-ion series, and unmatched ions respectively (Upper). (Middle) Amino acid sequences corresponding to the ion frag-
ments. (Lower) Plotted mass errors of detected versus expected peptide fragments. Errors of native peptide fragments were all <0.02 dalton. Expected masses
of all fragments are specified in SI Appendix, Table S5.
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(351st rank, SV endocytosis) or pla2g6 (653rd rank, lipid
composition) (Dataset S1). Altogether, our data analyses il-
lustrate the complexity and physiological importance of low-
abundance SV protein repertoires revealed by UD proteomics.
Discussion
In this study, we have used SVs purified from rodent brain as a
model for identifying and quantifying the “deep proteome,”
applying our proteomic workflow. SVs isolated from mammalian
brain are morphologically homogeneous (34) and share a set of
common proteins, with more than 90% containing the major SV
protein synaptophysin (2). Yet, they are heterogeneous with re-
spect to synapse types and neurotransmitter content. With the
proteomic workflow introduced here, we identified ∼1,500 pro-
teins in SVs, more than three times as many as previously reported
(2, 4, 7). Of these, we found 134 SV-resident proteins, of which 86
are of low abundance (<1 copy per SV). These proteins may
therefore be restricted to SV subsets, deduced from the findings
that they include previously missed vesicular transporters for
monoamines and acetylcholine, present in only a small percentage
of brain synapses. Of the ∼1,500 SV-fraction proteins, more than
200 have genetic associations with CNS diseases, highlighting the
importance of this deep diverse and previously hidden proteome
for proper brain functions. A resource database (Dataset S1) was
constructed to include all data on identification, quantitative dis-
tribution, and structural and functional annotations for each
protein detected in the SV fraction.
The increased peptide coverage of the “UD workflow” is
based on two major improvements in combination: 1) enhanced
cleavage using proteases in sequence and 2) the introduction of
an off-line orthogonal peptide separation prior to reversed-phase
liquid chromatography tandem mass spectrometry (LC-MS/MS).
These steps resulted in a remarkable increase in unique peptide
detection and have greatly expanded the protein inventory of
SVs, including highly homologous proteins within families. For
example, 40 Rab proteins, having high sequence homology (75 to
95%), but distinct trafficking functions (20), were identified.
Likewise, functionally characterized but hidden Syts, such as Syt7
(8–10), were detected, together with other family members of
unknown functions. Moreover, the high peptide yield of UD
proteomics allows unprecedented label-free and highly reli-
able quantification of most proteins in the dataset. We were
able to evaluate the copy numbers of many hundreds of pro-
teins, thereby providing a quantitative scope of the whole SV
proteome organization. When compared to previous quanti-
tative studies (2, 6), the results largely confirm copy numbers
on average per vesicle, except for three proteins—SNAP29,
vti1a, and ClC3—that have abundance scores too low to be
further considered as major SV proteins. On the other hand,
most detected proteins had copy numbers less than 1 per SV on
average, revealing much greater SV heterogeneity than
previously envisaged.
Our label-free quantification also allowed a quantitative
comparison of the proteomes of isolated nerve terminals and
purified SVs. This was not only the foundation for identifying
bona fide SV residents, but also for distinguishing between SV
resident and potential SV visitor proteins. Remarkably, about
50% of the SV residents are nontransmembrane proteins (Dataset
S1), highlighting the high degree of proteome organization, de-
spite molecular crowding at the synapse (6). For example, UD
proteomics revealed that, among nontransmembrane proteins,
Aak1 is a major SV-resident protein, having an SV/P2′ ratio of ∼4
and a copy number/SV of 1.5. Our functional assays indicated that
this kinase is essential to maintain high-frequency neurotransmis-
sion by accelerating SV recycling. Thus, our classification of SV
protein repertoires may facilitate functional studies and may result
in the identification of major regulators of synaptic transmission.
It needs to be borne in mind that SVs, starting from enriched
synaptosomes, are isolated solely based on their size and density.
Therefore, heterogeneity may also be caused, at least in part, by
the presence of membranes derived from different trafficking
steps, such as partially clathrin-uncoated vesicles, small endo-
somal vesicles, or SVs from axonal compartments en route to
nerve terminals. While these compartments are part of the same
recycling pathway and are expected to share vesicular
membrane-resident proteins, the “visitor” proteins are likely to
be different. This may explain the presence of endosomal-related
proteins (e.g., Stx7, AP3) or proteins of the AZ (e.g., Piccolo,
Bassoon) in the SV proteome. Moreover, we could not exclude
the possibility that the SV preparation is contaminated, even to a
small extent, with vesicles from other sources: for instance, small
vesicles artificially generated from larger membranes during
homogenization, or vesicles from the postsynaptic side. Indeed,
analysis of the UD-SV proteome using the SynGO resource (15)
has revealed a postsynaptic contamination of at least 4% based
on 691proteins that were annotated in SynGO. Regarding pos-
sible contaminants in the remaining 775 SV proteins in our
study, we cannot make a definitive calculation as these are not
annotated in the SynGO database.
A closer look at the defined SV-resident repertoire (proteins
with SV/P2′ iBAQ ratios of >2) (Dataset S1) provides important
leads toward a better understanding of SV molecular and func-
tional heterogeneity. Of 134 SV-resident proteins, 86 have copy
numbers <1/SV (SI Appendix, Fig. S8). The 40 most abundant SV-
resident proteins (in ranks 1 to 180) include all of the subunits of
V-ATPase, vesicular “tetraspanins” including SCAMPs, synapto-
physins, and synaptogyrins, Syts and SV2 proteins, as well as
membrane-associated synapsins and CSPs. VGLUT1/2 and
VGAT, vesicular transporters of the two major neurotransmitters
in the brain, glutamate (excitatory synapses) and γ-aminobutyric
acid (GABA) (inhibitory synapses), are also in this list. All these
proteins are likely present on SVs throughout the entire nervous
system.
Minor SV residents (<1 copy per SV, beyond rank 180) in-
clude proteins generally involved in membrane trafficking, such
as additional SNAREs, Rab GTPases, phospholipid kinases,
tethering complexes, and autophagy-related proteins. Their low
abundance suggests that they reside on a subset of vesicles within
synapses. For example, the copy number of the transmembrane
protein Atg9a was 1 per 25 SVs (SI Appendix, Fig. S3 and Table
S1), implying that 4% of vesicles in the synaptic compartment
may be recruited to an autophagic pool. As another possibility,
these proteins may be expressed specifically in a small subset of
synapses in specific brain regions. Indeed, this list includes the
known scarce neurotransmitter vesicular transporters VMAT2,
VAChT, Slc5a7, and VGLUT3, reflecting the functional hetero-
geneity of synapses (Fig. 3C and SI Appendix, Table S2). Inter-
estingly, our list also includes almost a dozen of hitherto unreported
transporter proteins.
Many SV proteins, whether classified as residents or potential
visitors, may have specific functions in regulating or maintaining
the performance of synapses. In fact, our UD proteomics have
detected over 200 proteins in the SV fraction known to be ge-
netically associated with neurological (mental, motor, and sen-
sory processing) disorders. Remarkably, a majority of these
proteins (76%) were found in low-abundance ranges and had
copy numbers of <0.04/SV. These neurological disorders likely
originate from various synaptic dysfunctions specific to discrete
neuronal populations of the nervous system. In fact, recent evi-
dence supports the idea of “synaptopathies” as a causal poly-
genic mechanism for psychiatric diseases (35–38). In the process
of evolution, abundant canonical proteins are often ancestral
components whereas proteins of low abundance tend to emerge
for new functions (39). In this respect, the deep diversified syn-
aptic proteome may account for mammalian- or human-specific








neurological diseases. This could be a key reason why, despite
technical difficulties, investigations of deep subcellular proteomes
beyond “average models” are necessary.
Materials and Methods
All animal experiments were performed in accordance with guidelines of
the Physiological Society of Japan, the German Animal Welfare Act, and
A
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Fig. 5. Aak1 is an SV-attached protein kinase essential for high-frequency neurotransmission. (A) SV/P2′ volcano plot of 69 kinases detected in the SV fraction
by UD proteomics. Labels indicate names of genes encoding proteins. Aak1 (circled in red) is one of the few identified SV-residents. (B) SV kinases in the
abundance curve. Aak1 is the most abundant of SV kinases. (C) Colocalization of exogenously expressed Aak1 and synaptophysin (SypHy) in cultured hippocampal
neurons. (Upper) Control TagRFP (red) and SypHy (green) images and their line-scanned profiles (Right). (Lower) TagRFP-Aak1 (red) and SypHy (green) images and
their line-scan profiles showing complete colocalization. (D) Lentivirus KD efficiency of Aak1 confirmed at DIV15 byWestern blot analysis. Hippocampal cells were
infected at DIV 11 to 12with lentivirus coexpressing GFP and shRNA targeting Aak1. (E) Aak1-KD enhanced STD of EPSCs and reduced estimated readily releasable
pool (RRP) size of SVs (Nq) evoked by a 20-Hz train of stimulation in Aak1-KD (red, n = 7) or shRNA control (black, n = 7) neurons. (F) LP935509 (1 μM) slowed both
fast and slow components of recovery from STD (100 Hz) at the calyx of Held (red traces, n = 6, stimulation protocol indicated on the Top). EPSCs at different
interstimulus intervals (ISIs) are shown in Insets. (G) Aak1-KD slowed endocytic SV fluorescence in response to stimulation in pHluorin analyses in hippocampal
neurons. Aak1-KD (red), n = 16 neurons, 51 boutons; and control (black), n = 10 neurons, and 20 boutons. (H) LP935509 (1 or 10 μM) prolonged the SV endocytic
half-time (P < 0.001, n = 6 at 1 μM and n = 4 at 10 μM: 4; one-way ANOVA: F(2, 13) = 16.81] without affecting exocytic [P = 0.059, F(2, 13) = 2.53] or presynaptic Ca2+
current magnitudes [P = 0.511, F(2, 13) = 0.15] in membrane capacitance measurements at the calyx of Held. (I) LP935509 (1 μM) impaired fidelity of glutamatergic
neurotransmission at 100-Hz at the calyx of Held. (Top) Postsynaptic APs evoked by presynaptic APs in the presence (red) or absence (black) of LP935509 in
presynaptic terminals. (Bottom) Percentages of postsynaptic APs elicited by presynaptic APs, controls (n = 6) and the Aak1 inhibitor (n = 6).
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regulations at the Okinawa Institute of Science and Technology, at the Max-
Planck Institute for Biophysical Chemistry, and at Doshisha University.
Brain Synaptosomes and SV Purifications. Synaptosomes (P2′) and SVs were
purified from whole brain of 4- to 6-wk-old Sprague–Dawley rats following
the same protocols used in ref. 2 and previously described in ref. 34 for SV,
and in ref. 4 for P2′. The quality of all P2′ and SV purification procedures was
controlled by Western blots of synaptic protein markers and by EM. Extended
descriptions of biochemical, imaging, and electrophysiological procedures and
analyses are provided in SI Appendix, SI Materials and Methods.
UD Proteomics Sample Preparation and MS.
Sequential protein digestion. Fifty micrograms of proteins extracted from P2′ or
SV were resuspended into 200 μL of buffer containing 8 M urea, 100 mM
Tris·HCl, pH 8 (“urea buffer”) and placed onto a Pall Nanosep Omega filter
(Sigma). After shaking 1 min at 850 rpm at room temperature (Eppendorf
Thermomixer), samples were centrifuged during 13 min at 6,400 × g (con-
ditions that were optimal to remove all of the liquid from the upper
chamber using a TOMY Kintaro KT-24 centrifuge). After repeating these
steps two times, proteins were resuspended with 200 μL of urea buffer
containing 50 mM iodoacetamide and incubated in darkness for 1 h at room
temperature. The alkylation was then stopped by centrifuging as above and
by resuspending protein samples with 200 μL of urea buffer containing 25
mM dithiothreitol. Unfolded proteins were subsequently washed with
20 mM ammonium bicarbonate. Proteolytic enzymes were used in a ratio of
1:50 with proteins. To generate peptides, a first digestion step (“trimming”)
was performed using endoproteinase lys-C (Promega) for 6 h at 37 °C, fol-
lowed by a second digestion step overnight (16 to 18 h) at 37 °C using a
































































































































































































































Total SV fraction SV-resident
Fig. 6. Diversity of neuronal functions and dysfunctions related to the UD-SV proteome. (A) Functional mosaic of the SV proteome. Each protein detected in
the SV fraction by UD proteomics was associated with one or more functional keywords. (Top Left) Sunburst diagrams show distributions of the functional
categories (inner circle) and subcategories (outer circle) represented in the total SV fraction proteome and in the SV-resident repertoire. Shown is a list of
functional keywords (Left) and subcategories (Right) with number of proteins representing each category (for details of protein functional annotations, see
Dataset S1). (B) The deep low-abundant SV proteome is related to brain diseases. Proteins detected in the SV fraction having “disease(s) caused by mutation(s)
affecting the gene represented in the entry” were marked, and their rank in the iBAQ-abundance curve is specified. The analysis was performed manually using
the Uniprot and GeneCards databases for human diseases. Markers indicate proteins associated with cognitive (purple), motor (red), and/or sensory processing
(yellow) disabilities. The vertical dashed line indicates rank 409, the number of proteins identified by a previous SV proteomics study [Takamori et al. (2)]. Proteins
to the right hand of the dashed line were mostly revealed by UD proteomics (see Dataset S1 for a listing of all disease names and protein associations).








peptides were acidified with 1% trifluoroacetic acid, concentrated, and
dried using an EZ-2 Elite evaporator (SP Scientific).
Orthogonal peptide separations. To separate peptides, off-line ERLIC or ERLIC-
based separation was performed (14). The following conditions were
adapted and optimized to obtain the highest number of identified proteins
from P2′ and SV samples. Mobile phase solvent preparation was as follows:
Solvents were freshly prepared for each experiment using liquid chroma-
tography/mass spectrometry grade acetonitrile (ACN), formic acid (FA), and
water from Thermo Fisher Chemicals. Solvent A was prepared as follows: 90%
ACN, 0.1% FA. Ammonium hydroxide (NH4OH, 25% weight/weight [wt/wt] in
water; Fluka) was then added to adjust pH at 4.5. Solvent B was prepared as
follows: 30% ACN, 0.1% FA. The digested peptide mixture was resuspended
with 20 μL of solvent A and injected into a weak anion exchange PolyWax
column (1-mm inner diameter × 150 mm, 5-mm particle size, 300-Å pore size;
PolyLC Inc.) using a PAL autosampler (CTC Analytics) for automatic injection
and fractions collection, using a gradient mode (3 min solvent A, to 10% B in
7 min, 10% B to 25% B in 24 min, 25% B to 70% B in 16 min, 70% B to 81% B
in 6 min, 81% B to 100% B in 3 min, with final wash at 100% B for 6 min and
reequilibration at 100% A for 20 min) at a flow rate of 40 μL/min. Twenty-four
fractions were collected every 3 min between 0 and 72 min and subsequently
concentrated to dryness using a speed vacuum Genevac EZ-2 Elite (SP
Scientific).
MS. Dried peptides were resuspended in 30 μL of 0.1% FA and analyzed using
a Q-Exactive Plus Orbitrap hybrid mass spectrometer (Thermo Scientific)
equipped with an Ultimate 3000 nano-high-pressure liquid chromatography
(nano-HPLC) system (Dionex), HTC-PAL autosampler (CTC Analytics), and a
nanoelectrospray ion source. Five microliters of each sample were injected
into a Zorbax 300SB C18 capillary column (0.3 × 150 mm; Agilent Technol-
ogies) and heated at 40 °C. A 1-h HPLC gradient was employed (1% B to 32%
B in 45 min, 32% B to 45% B in 15 min, with final wash at 75% B for 5 min
and reequilibration at 1% B for 10 min.) using 0.1% FA in distilled water as
solvent A, and 0.1% FA in ACN as solvent B. A flow rate of 3.5 μL/min was
used for peptide separation. Temperature of the heated capillary was
300 °C, and a 1.9-kV spray voltage was applied to all samples. The mass
spectrometer settings were as follow: full MS scan range 350 to 1,500 m/z
with a mass resolution of 70,000, 30-μs scan time, and automatic gain control
set to 1.0E6 ions, and fragmentation MS2 of the 20 most intense ions.
Protein identification. Protein identification was done using Proteome Dis-
coverer software v2.1 (Thermo Scientific) andMascot 2.6 (Matrix Science) as a search
engine. A database downloaded from UniprotKB Rattus norvegicus (proteome ID
UP000002494) was used with search parameters as follows: trypsin enzyme, up to
two miscleavages, with precursor and fragment mass tolerance set to 10 parts per
million and 0.02 Da, respectively. Cysteine carbamidomethylation, methionine
oxidation, asparagine and glutamine deamidation, and N-terminal protein
acetylation were set as variable modifications. The results were filtered using a
false discovery rate of <1% as a cutoff threshold, determined by the Percolator
algorithm in Proteome Discoverer software.
Quantitative proteomic data statistical analyses. For the volcano plot, iBAQ data
obtained from Proteome Discoverer were used for statistical analysis using R
software version 3.2.5 (R Project for Statistical Computing). Quasi-Poisson
generalized linear models were generated (y ∼1, y ∼ treat) and compared
using analysis of deviance for generalized linear model fits (Anova) to obtain P
values, using an F-test, and adjusted with the Benjamini–Hochberg method.
Data Availability. Proteomic raw data files data have been deposited in the
Japan Proteome Standard Repository Database (accession no. JPST000968).
All other study data are included in the article, Dataset S1, and SI Appendix.
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